Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentle Wounding to Stimulate Hair Follicle Neogenesis in CCCA
NCT03491267Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2018
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of tretinoin in central centrifugal cicatricial alopecia (CCCA) (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Change in Number of New Hairs at 6 months. Started Jan 2018; status: completed.
02
Drugs
tretinoin
03
Conditions
central centrifugal cicatricial alopecia (CCCA)
Beyond the preview
Go deeper on NCT03491267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03491267.